Posted on March 29, 2024 by: jenn Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
Posted on March 29, 2024 by: jenn Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical